Pacific Biosciences of California, Inc. Share Price
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.360 USD | -5.56% |
|
-8.72% | -27.27% |
| Market Cap | 422M 370M 342M 315M 594M 40.73B 603M 4.09B 1.6B 19.93B 1.59B 1.55B 68.67B | P/E 2026 * |
-3.32x | P/E 2027 * | -2.89x |
|---|---|---|---|---|---|
| Enterprise Value | 422M 370M 342M 315M 594M 40.73B 603M 4.09B 1.6B 19.93B 1.59B 1.55B 68.67B | EV / Sales 2026 * |
2.52x | EV / Sales 2027 * | 2.18x |
| Free-Float |
91.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | -5.56% | ||
| 1 week | -8.72% | ||
| Current month | -19.05% | ||
| 1 month | -2.86% | ||
| 3 months | -21.84% | ||
| 6 months | -42.37% | ||
| Current year | -27.27% |
| 1 week | 1.34 |  | 1.55 |
| 1 month | 1.3 | | 1.84 |
| Current year | 1.09 | | 2.73 |
| 1 year | 1.09 | | 2.73 |
| 3 years | 0.85 | | 13.7 |
| 5 years | 0.85 | | 35.58 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 13/09/2020 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 30/03/2025 |
Mark van Oene
COO | Chief Operating Officer | 53 | 07/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 31/12/2003 |
Randy Livingston
BRD | Director/Board Member | 72 | 31/12/2008 |
Marshall Mohr
BRD | Director/Board Member | 69 | 17/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06/26 | Free | Director | 223,492 | 0.0720% | ||
| 03/06/26 | Free | Director | 223,492 | 0.0720% | ||
| 03/06/26 | Free | Director | 223,492 | 0.0720% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.56% | -8.72% | -0.73% | -89.69% | 447M | |
| -1.17% | -0.43% | +26.88% | -2.24% | 198B | |
| -1.33% | +0.47% | +5.82% | -17.71% | 144B | |
| +2.24% | -13.25% | -31.90% | +1.58% | 122B | |
| -0.59% | -1.97% | -57.77% | -18.13% | 65.44B | |
| -0.85% | -7.40% | +11.13% | -8.26% | 49.36B | |
| +0.65% | -0.59% | -23.34% | -31.15% | 44.74B | |
| -0.91% | -2.82% | +14.27% | +4.58% | 37.13B | |
| -3.10% | -4.20% | +24.35% | +27.80% | 36.23B | |
| -0.19% | +0.06% | -23.00% | -9.43% | 28.7B | |
| Average | -1.44% | -3.76% | -5.43% | -14.26% | 72.65B | |
| Weighted average by Cap. | -1.09% | -2.92% | -1.75% | -6.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 168M 147M 136M 125M 236M 16.18B 240M 1.63B 637M 7.92B 630M 616M 27.28B | 194M 170M 157M 145M 273M 18.7B 277M 1.88B 737M 9.15B 728M 712M 31.53B |
| Net income | -129M -113M -104M -95.8M -181M -12.4B -184M -1.25B -488M -6.07B -483M -472M -20.9B | -151M -132M -122M -113M -212M -14.57B -216M -1.46B -574M -7.13B -567M -555M -24.57B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$1.360 | -5.56% | 10,867,228 |
| 17/07/26 | US$1.440 | -3.36% | 7,078,875 |
| 16/07/26 | US$1.490 | -2.61% | 4,291,924 |
| 15/07/26 | US$1.530 | +2.00% | 3,552,632 |
| 14/07/26 | US$1.500 | +0.67% | 2,740,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
